Temasek Holdings (Private) LTD Vir Biotechnology, Inc. Transaction History

Temasek Holdings (Private) LTD

$24.5 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $15.8 Million - $18.6 Million	-681,362 Reduced 11.72%	5,133,610 $126 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $2.33 Million - $3.22 Million	104,462 Added 1.83%	5,814,972 $135 Million
Q4 2022 May 15, 2023	SELL	$19.96 - $28.22 $6.51 Million - $9.21 Million	-326,311 Reduced 5.41%	5,710,510 $145 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $6.51 Million - $9.21 Million	-326,311 Reduced 5.41%	5,710,510 $145 Million
Q3 2022 May 15, 2023	BUY	$18.26 - $31.1 $7.93 Million - $13.5 Million	434,268 Added 7.75%	6,036,821 $116 Million
Q3 2022 Apr 05, 2023	BUY	$18.26 - $31.1 $5.96 Million - $10.1 Million	326,311 Added 5.71%	6,036,821 $116 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $7.93 Million - $13.5 Million	434,268 Added 7.75%	6,036,821 $116 Million
Q1 2022 May 15, 2023	SELL	$21.19 - $40.01 $2.29 Million - $4.32 Million	-107,957 Reduced 1.89%	5,602,553 $144 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $1.38 Million - $2.61 Million	65,262 Added 1.18%	5,602,553 $144 Million
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $6.93 Million - $12.1 Million	-223,754 Reduced 3.88%	5,537,291 $232 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $5.21 Million - $8.14 Million	149,170 Added 2.66%	5,761,045 $251 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $3.61 Million - $4.75 Million	93,231 Added 1.69%	5,611,875 $265 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $491,109 - $1.55 Million	18,645 Added 0.34%	5,518,644 $283 Million
Q4 2019 Feb 14, 2020	BUY	$11.83 - $15.85 $65.1 Million - $87.2 Million	5,499,999 New	5,499,999 $69.2 Million

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$116 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$114 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$91.3 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$39.1 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$24.8 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Account